Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy.

Journal: Acta pharmaceutica Sinica. B •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Tan X, Li M, Lan Z, et al. (2026). "Dual-mode hepatoprotective nanoplatform combines ROS scavenging and FGF21 activation for precision acute liver injury therapy.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.03.005